Woodline Partners’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-142,863
Closed -$553K 877
2025
Q2
$553K Buy
+142,863
New +$773K ﹤0.01% 848
2024
Q2
Sell
-214,245
Closed -$2.18M 556
2024
Q1
$2.18M Buy
+214,245
New +$2.18M 0.02% 423
2023
Q1
Sell
-1,304,024
Closed -$21.5M 627
2022
Q4
$21.5M Buy
1,304,024
+285,933
+28% +$3.21M 0.3% 95
2022
Q3
$13M Buy
1,018,091
+467,406
+85% +$6.9M 0.19% 162
2022
Q2
$6.44M Sell
550,685
-295,933
-35% -$1.82M 0.11% 222
2022
Q1
$5.16M Buy
846,618
+225,940
+36% +$1.66M 0.09% 240
2021
Q4
$5.68M Buy
620,678
+271,855
+78% +$2.89M 0.08% 269
2021
Q3
$3.94M Buy
+348,823
New +$4.24M 0.07% 294

Other funds holding ALT